Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Asaf Danziger
Age : 55
Public asset : 9,170,876 USD
Country of residence : Unknown
Linked companies : NovoCure Limited

Biography of Asaf Danziger 
Currently, Asaf Danziger occupies the position of Chief Executive Officer & Director at NovoCure Ltd. and Co-Managing Director at NovoCure GmbH (a subsidiary of NovoCure Ltd.). In the past Mr. Danziger occupied the position of Chief Executive Officer of Cybro Medical Ltd. and Communications & Electronics Officer at Israel Defense Forces. He received an undergraduate degree from Ben-Gurion University of the Negev.


Current positions of Asaf Danziger 
Holdings of Asaf Danziger 
Asaf Danziger : Personal Network 
Most Read News 
06/22ELON MUSK : Musk says Tesla's new car factories 'losing billions of dollars'
RE
06/15ELON MUSK : Elon Musk appeals decision concerning SEC settlement over Twitter posts
RE
04:07aWARREN BUFFETT : Buffett's Berkshire buys more Occidental shares, raises stake to about 16.4%
RE
06/23MARK MILLER : Column-Want to do something about your ailing retirement savings? Don't
RE
06/22TREVOR MILTON : Nikola founder Trevor Milton faces new fraud charge
RE
06/13ELON MUSK : Musk to attend Twitter staff Q&A meet for first time since launching bid
RE
06/22RUPERT MURDOCH : Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/15PETER WENNINK : Samsung's Lee discusses smooth supply of "essential" chip equipment with ASML's Wennink
RE
06/14HAROLD HAMM : Billionaire-founder Harold Hamm offers to take Continental private in $25-billion deal
RE
06/21ELON MUSK : Musk says there are still a few unresolved matters with Twitter deal
RE
More news


© 2022 People and Ownership :   
Asaf Danziger : Connections 


Latest news about Asaf Danziger 
04/28TRANSCRIPT : NovoCure Limited, Q1 2022 Earnings Call, Apr 28, 2022
CI
02/24TRANSCRIPT : NovoCure Limited, Q4 2021 Earnings Call, Feb 24, 2022
CI
2021INSIDER BUY : NovoCure
MT
2021TRANSCRIPT : NovoCure Limited, Q3 2021 Earnings Call, Oct 28, 2021
CI
2021TRANSCRIPT : NovoCure Limited, Q2 2021 Earnings Call, Jul 29, 2021
CI
2021TRANSCRIPT : NovoCure Limited, Q1 2021 Earnings Call, Apr 29, 2021
CI
2021NOVOCURE : Insiders at NovoCure (NVCR) Make Significant Stock Sales Extends the Trend of Last Quarter
MT
More news